Clinical Observation of Furong Tongmai Capsules Combined with Liraglutide in the Treatment of Diabetes Mellitus Type 2
Objective To investigate the effects of Furong Tongmai Capsules combined with liraglutide on the blood glucose-related indexes,carotid atherosclerotic plaque area and fibrinogen(Fib)level in patients with diabetes mellitus type 2(T2DM).Methods A total of 90 patients with T2DM admitted to the hospital from January 2021 to December 2022 were selected and divided into the observation group and the control group by the random number table method,with 45 cases in each group.The patients in the two groups were given subcutaneous injection of Liraglutide Injection,on this basis,the patients in the observation group were given Furong Tongmai Capsules.Both groups were treated continuously for three months.Results After treatment,the traditional Chinese medicine(TCM)syndrome score,fasting blood glucose(FBG),2-hour postprandial blood glucose(2 hPG),glycosylated hemoglobin(HbA1C)and Fib levels in the two groups significantly decreased(P<0.05),and those in the observation group were significantly lower than those in the control group(P<0.05).After treatment,the carotid atherosclerotic plaque area in the two groups significantly decreased(P<0.05),and that in the observation group was significantly smaller than that in the control group(P<0.05).The incidence of adverse reactions in the observation group was significantly lower than that in the control group(8.89% vs.24.44%,P<0.05).Conclusion Furong Tongmai Capsules combined with liraglutide can effectively decrease the blood glucose-related index levels,improve TCM syndromes and blood coagulation function,and relieve the carotid atherosclerosis in patients with T2DM.
Furong Tongmai Capsulesliraglutidediabetes mellitus type 2carotid atherosclerosisblood glucosefibrinogenTCM syndrome
国家科技期刊平台
NSTL
万方数据
